Clinical trial

HIV, Buprenorphine, and the Criminal Justice System

NCT01550341

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-02-23

PhaseNA

Study timeline

Study start (actual)2012-02-23Date precision: day

Registry last updated2020-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Human Immunodeficiency Virusunresolved

Acquired Immunodeficiency Syndromeunresolved

Opiate Addictionunresolved

Drug Dependenceunresolved

Interventions

Buprenorphine/naloxoneDRUG

Placebo Oral TabletDRUG

Sponsors & collaborators

Yale Universitylead sponsor

George Mason Universitycollaborator

Howard Universitycollaborator

National Institute on Drug Abuse (NIDA)collaborator

Mapped research locations

Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01550341 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.